Existing therapies for neurodegenerative diseases like Parkinson's and Alzheimer's address
only their symptoms and do not prevent disease onset. Common therapeutic agents, such as …

The aggregation of amyloid-β protein (Aβ) into oligomers and amyloid fibrils is closely
related to Alzheimer's disease (AD). Aβ40 and Aβ42, as two most prominent isoforms of Aβ …

As one of the expensive and heavy illnesses, Alzheimer's disease (AD) has plagued
mankind for a long time. The deposition of amyloid-β (Aβ) plaques in the brain is AD's main …

The aggregation of the amyloid β (Aβ) peptide is a major hallmark of Alzheimer's disease.
This peptide can aggregate into oligomers, proto-fibrils and mature fibrils, which eventually …

The aggregation of the amyloid-β (Aβ) peptide is a major hallmark of Alzheimer's disease.
This peptide can aggregate into oligomers, proto-fibrils, and mature fibrils, which eventually …

Metal ions have been found to play an important role in the formation of extracellular β-
amyloid plaques, a major hallmark of Alzheimer's disease. In the present study, the …

Amyloid-β (Aβ) and its assemblies play important roles in the pathogenesis of Alzheimer's
disease (AD). Recent studies conducted by experimental and computational researchers …

The aggregation of amyloid‐β 42 (Aβ42) is directly related to the pathogenesis of
Alzheimer's disease. Here, we have investigated the early stages of the aggregation …

Beta amyloid peptide Aβ 1–42 (Aβ42) has a unique dual role in the human organism, as
both the peptide with an important physiological function and one of the most toxic biological …

The use of fluorescently tagged amyloid peptides, implicated in Alzheimer's disease, to
study their aggregation at low concentrations is a common method; however, the fluorescent …